# Senolytics: What They Are, How They Work & Risks

**By TelosRX Editorial Team** · 2026-11-04

**Senolytics are experimental drugs designed to clear senescent "zombie" cells, which stop dividing but linger and release inflammatory signals. None is approved for aging. [TelosRX](https://telosrx.com) explains what early human studies actually found.**

Senolytics might be the most hyped word in longevity science right now. Searches for "senolytics drugs," fisetin, and dasatinib have all climbed this month. The pitch is bold: clear out old, damaged cells and slow aging itself.

The real story is more interesting, and more cautious. Here's what senolytics are, how they're meant to work, and what the evidence can and can't tell you yet.

## What Are Senolytics?

The name comes from two parts. "Seno" refers to senescence (a cell's permanent retirement from dividing). "Lytic" means to break apart. A senolytic, then, is a compound meant to selectively destroy senescent cells.

The goal is precision. Researchers want to remove the harmful retired cells while leaving healthy ones alone. That's harder than it sounds, which is why the field is still mostly in trials.

## What Are Senescent Cells, Exactly?

Every cell has a limited number of divisions. Damage from stress, radiation, or DNA errors can also force a cell to stop early. When that happens, the cell enters senescence instead of dying.

That's not all bad. Senescence is a built-in brake that helps stop damaged cells from becoming cancer. Senescent cells also help with wound healing in the short term.

The trouble starts when they pile up. Your immune system usually clears them. With age, clearance slows, and senescent cells accumulate in many tissues.

## Why "Zombie Cells" Cause Problems

Senescent cells don't just sit quietly. They release a cocktail of inflammatory signals called the SASP (senescence-associated secretory phenotype, or the cell's inflammatory exhaust).

-   **Inflammatory cytokines** that can fuel chronic, low-grade inflammation
-   **Enzymes** that break down surrounding tissue
-   **Signals** that can push nearby healthy cells toward senescence

Scientists call this low-level, age-linked inflammation "inflammaging." In animal studies, senescent cell buildup is linked with frailty, joint damage, and organ decline. That's the target senolytics aim at.

## How Do Senolytics Work?

Senescent cells resist dying. They switch on survival pathways, often called SCAPs (senescent cell anti-apoptotic pathways). These act like "don't kill me" switches.

Senolytics work by flipping those switches off. Once the survival signals drop, the senescent cell undergoes apoptosis (programmed cell death). Healthy cells, which don't depend on those same pathways as heavily, are mostly spared.

Because senescent cells take weeks to rebuild, many trials use "hit-and-run" dosing. That means short, intermittent courses rather than daily use. It's a key difference from most medications.

## Senolytics vs Senomorphics

You'll often see these two terms mixed up. They aren't the same thing.

| Feature | Senolytics | Senomorphics |
| --- | --- | --- |
| Main action | Kill senescent cells | Quiet the SASP without killing cells |
| Typical dosing in studies | Short, intermittent courses | Often continuous |
| Examples studied | Dasatinib plus quercetin, fisetin, navitoclax | Rapamycin, metformin |
| Approved for aging? | No  | No  |

Rapamycin often appears on senolytic lists, but it's a senomorphic. We cover it in depth in our [rapamycin for longevity Q&A](https://www.telosrx.com/blogs/hormone-longevity/rapamycin-for-longevity-questions-answered).

## Senolytic Drugs Being Studied

Only a handful of senolytic drugs have reached human testing. Here's the short list.

-   **Dasatinib plus quercetin (D+Q):** Dasatinib is an approved leukemia drug. Quercetin is a plant flavonoid found in onions and apples. Together they hit different senescent cell types.
-   **Fisetin:** A flavonoid found in small amounts in strawberries and apples. It's sold as a supplement, but supplement doses differ from trial doses.
-   **Navitoclax:** An experimental cancer drug that blocks BCL-2 family survival proteins. Its blood-platelet side effects limit use.
-   **Targeted injectables:** Several companies are testing locally injected senolytics for eye and joint conditions.

## A Short History of Senolytics

The idea is younger than you might think. In 2011, researchers showed that clearing senescent cells in genetically engineered mice delayed several age-related problems. That proved the concept, but it needed a drug.

In 2015, a team at the Mayo Clinic screened compounds for ones that killed senescent cells. Dasatinib and quercetin stood out, and the term "senolytic" took off. The first small human studies followed in 2019.

So the field is barely a decade old. That's fast for science, and slow for anyone hoping for a pill next year.

## How Researchers Measure Senescent Cells

You can't count zombie cells with a standard blood test. Researchers rely on markers in tissue samples or blood.

-   **p16INK4a:** a protein that rises when cells stop dividing.
-   **SA-β-gal:** an enzyme stain that marks many senescent cells.
-   **SASP factors:** inflammatory proteins measured in blood.

Each marker has limits, and none is perfect on its own. That measurement gap makes it hard to know who might benefit, or whether a dose worked.

## What the Mouse Research Showed

The excitement started in animals. A 2018 study in _Nature Medicine_ found that [senolytics improved physical function and increased lifespan in old mice](https://pubmed.ncbi.nlm.nih.gov/29988130/). The team used intermittent dasatinib plus quercetin.

Another 2018 study, in _EBioMedicine_, reported that fisetin reduced senescence markers and extended health and lifespan in mice. These results put senolytics on the map. Mouse results, though, often fail to carry over to people.

## What Early Human Studies Found

Human data are still small and early. Two pilot studies get cited most often.

-   **Lung fibrosis pilot (2019):** A [first-in-human, open-label study](https://pubmed.ncbi.nlm.nih.gov/30616998/) gave D+Q to 14 people with idiopathic pulmonary fibrosis. Researchers reported improvements in some physical function measures. There was no placebo group.
-   **Diabetic kidney disease (2019):** A [preliminary report in _EBioMedicine_](https://pubmed.ncbi.nlm.nih.gov/31542391/) found that a short D+Q course reduced senescent cell markers in fat tissue samples.

These studies show senolytics can reach and affect senescent cells in humans. They don't show that senolytics slow aging or extend human lifespan.

## What Senolytics Can't Do (Yet)

It's easy to read the headlines and expect too much. Here's where the evidence currently stands.

-   No senolytic is FDA-approved for aging or longevity.
-   No trial has shown that senolytics extend human lifespan.
-   Some later trials have reported mixed or null results.
-   Long-term safety of repeated courses is unknown.
-   Researchers still lack a simple blood test for senescent cell burden.

Some studies have also flagged the timing question. If senescent cells help repair tissue after an injury, clearing them at the wrong moment could slow healing. That's one reason trials use short, spaced-out courses.

Senescent cells also have jobs. They help with wound repair and act as a cancer brake. Wiping them out too aggressively could carry risks researchers don't yet understand.

## Risks and Side Effects of Senolytics

Senolytics are powerful compounds, not gentle wellness add-ons. Side effects reported in trials depend on the drug.

-   **Dasatinib:** can cause fluid retention, low blood counts, and stomach upset at cancer doses.
-   **Navitoclax:** can sharply lower platelets, raising bleeding risk.
-   **Quercetin and fisetin:** can interact with certain medications, including blood thinners.

Pilot studies reported mostly mild effects with short courses. Still, those studies were small and closely monitored. Self-experimenting with dasatinib outside a trial is risky.

## Should You Take Senolytic Supplements?

Fisetin and quercetin supplements are easy to buy. That doesn't mean they act as senolytics at the doses sold. Most supplement products haven't been tested for that effect in humans.

Supplements also aren't reviewed by the FDA for safety or effectiveness before sale. Quality and actual content can vary. Talk with a clinician before adding them, especially if you take other medications.

## Foods With Senolytic Compounds

Some foods contain flavonoids studied as senolytics. Strawberries, apples, onions, capers, and kale are common examples. Eating them is healthy for many reasons.

The amounts in food, though, are far lower than research doses. Think of a colorful diet as good general nutrition, not a senolytic therapy. No amount of strawberries replaces a clinical trial.

## Evidence-Based Ways to Support Healthy Aging Today

While senolytics stay in trials, several everyday habits have far stronger evidence behind them. Regular exercise, solid sleep, a whole-food diet, and not smoking all matter.

Some researchers think exercise may lower senescent cell burden, though data are still emerging. Cellular recycling, called autophagy, is another hot topic. Read our explainer on [what autophagy is and how it works](https://www.telosrx.com/blogs/hormone-longevity/what-is-autophagy-how-it-works-benefits).

Interested in a clinically supervised longevity option? Explore [NAD+ nasal spray at TelosRX](https://www.telosrx.com/pages/nad-nasal-spray). It is not a senolytic, and compounded NAD+ is not FDA-approved. Prescriptions are subject to medical approval by a licensed provider.

## How TelosRX Thinks About Longevity Science

TelosRX is an asynchronous telehealth service. You complete a secure intake online, and a licensed provider reviews it on their own schedule. No live video visit is required.

We don't prescribe senolytics, and we won't overpromise on any longevity compound. For a practical, step-by-step plan, see our guide on [how to lower biological age](https://www.telosrx.com/blogs/hormone-longevity/how-to-lower-biological-age-guide).

## Frequently Asked Questions

### What drugs are senolytics?

The main senolytic drugs studied in humans are dasatinib combined with quercetin, fisetin, and navitoclax, plus a few locally injected candidates. Dasatinib is approved as a leukemia drug, while the others are investigational or sold as supplements. None is approved for aging. Rapamycin and metformin are senomorphics, not senolytics.

### Do senolytics actually work in humans?

Early pilot studies show senolytics can reduce senescent cell markers in humans, and one small lung fibrosis study reported some physical function improvements. These studies were small, short, and mostly uncontrolled. No trial has shown that senolytics slow human aging or extend lifespan, so the honest answer is not yet proven.

### Is fisetin a senolytic?

Fisetin acted as a senolytic in mouse studies, where a 2018 paper reported it reduced senescence markers and extended lifespan. Human evidence is limited, and supplement doses often differ from research doses. Fisetin supplements are not FDA-approved for any condition, so check with a clinician before using them.

### What is the difference between senolytics and senomorphics?

Senolytics kill senescent cells by turning off their survival pathways. Senomorphics leave senescent cells alive but quiet their inflammatory signals. Senolytics are usually studied in short, intermittent courses, while senomorphics like rapamycin are often taken more regularly. Neither class is approved for slowing aging in people today.

### Are senolytics safe?

Safety depends on the specific drug and dose. Dasatinib can cause fluid retention and low blood counts, and navitoclax can lower platelets. Short courses in small pilot studies were mostly well tolerated, but long-term safety is unknown. Senolytics should only be used under medical supervision, ideally within a clinical trial.

### Can senolytics reverse aging?

No study has shown that senolytics reverse aging in people. In mice, clearing senescent cells improved some measures of physical function and lifespan. Human trials so far are small and measure markers, not aging itself. Any claim that a senolytic supplement makes you biologically younger goes well beyond the current evidence.

_TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._

Start your private evaluation at [TelosRX](https://telosrx.com).

**Tags:** dasatinib and quercetin, explainer, fisetin, longevity research, senescent cells, senolytic drugs, senolytics

---

> Source: [Telos RX](https://www.telosrx.com/blogs/hormone-longevity/senolytics-explained)
